endocrine system diseases

Showing 1 - 25 of 96

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Type 1 Diabetes, Metabolic Disease, Endocrine System Diseases Trial (Support platform)

Not yet recruiting
  • Type 1 Diabetes
  • +4 more
  • Support platform
  • (no location specified)
Sep 29, 2023

Diabetes, Metabolic Disease, Glucose Metabolism Disorders Trial in Bern (Device: Sokru device)

Active, not recruiting
  • Diabetes Mellitus
  • +3 more
  • Device: Sokru device
  • Bern, Switzerland
    University of Bern
Jun 26, 2023

Polycystic Ovary Syndrome in Colombia Study.

Recruiting
  • Polycystic Ovary Syndrome
  • +2 more
  • Diagnostic Ultrasound
  • Venous puncture
  • Sabaneta, Antioquia, Colombia
    Colmédicos S.A.S
Jun 21, 2023

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders (Including Diabetes) Trial in Canada (Support-t)

Not yet recruiting
  • Diabetes Mellitus
  • +6 more
  • Support-t
  • Gatineau, Canada
  • +3 more
Jun 16, 2023

Trabecular Bone Score in Multiple Sclerosis

Completed
  • Multiple Sclerosis
  • +2 more
  • sm tbs group
  • Messina, Italy
    IRCCS Centro Neurolesi Bonino Pulejo
Mar 31, 2023

Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Greenville (eneboparatide, Placebo)

Not yet recruiting
  • Chronic Hypoparathyroidism
  • +2 more
  • eneboparatide
  • Placebo
  • Greenville, North Carolina
    Physician's East Endocrinology
Mar 9, 2023

Hormonal Contributors to COVID-19 Infection (COV-ENDO)

Active, not recruiting
  • COVID-19 Pandemic
  • Endocrine System Diseases
  • blood testing
  • Milan, Italy
    Istituto Auxologico Italiano IRCCS
Mar 6, 2023

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Guangzhou (AndroidAPS-rt-CGM;, sensor augmented pump(SAP);)

Recruiting
  • Diabetes Mellitus
  • +6 more
  • AndroidAPS-rt-CGM;
  • sensor augmented pump(SAP);
  • Guangzhou, Guangdong, China
    Jinhua Yan
Feb 12, 2023

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Beverly Hills, California
  • +22 more
Jan 30, 2023

Diabetes Type 2, Diabetes, Glucose Metabolism Disorders Trial in China (Tirzepatide, Placebo)

Not yet recruiting
  • Diabetes Type 2
  • +4 more
  • Hefei, Anhui, China
  • +28 more
Jan 11, 2023

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))

Active, not recruiting
  • Diabetes Mellitus
  • +6 more
  • Nagoya-shi, Aichi, Japan
  • +43 more
Jan 16, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial (VCTX211)

Not yet recruiting
  • Diabetes Mellitus
  • +6 more
  • VCTX211
  • (no location specified)
Sep 30, 2022

Rare and Atypical Diabetes Network

Recruiting
  • Diabetes Mellitus
  • +6 more
    • Aurora, Colorado
    • +13 more
    Sep 14, 2022

    Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial (DWP16001, Dapagliflozin Tablet)

    Not yet recruiting
    • Diabetes Mellitus
    • +4 more
    • (no location specified)
    Aug 16, 2022

    Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo)

    Active, not recruiting
    • Hypoparathyroidism
    • +2 more
    • TransCon PTH
    • Placebo
    • San Francisco, California
    • +20 more
    Aug 5, 2022

    Type2 Diabetes, Diabetes, Diabetes, Type 2 Trial in Worldwide (Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo)

    Recruiting
    • Type2 Diabetes
    • +7 more
    • Tirzepatide Dose 1
    • +2 more
    • Birmingham, Alabama
    • +55 more
    Aug 8, 2022

    Type 1 Diabetes, Pregnancy Related, Glucose Metabolism Disorders Trial in Calgary, Toronto (Tandem t:slim X2 insulin pump with

    Recruiting
    • Type 1 Diabetes Mellitus
    • +4 more
    • Tandem t:slim X2 insulin pump with Control IQ technology
    • Calgary, Alberta, Canada
    • +1 more
    Aug 4, 2022

    Intestinal Metabolic Reprogramming asKey Mechanism of Gastric

    Active, not recruiting
    • Obesity
    • +4 more
      • Pittsburgh, Pennsylvania
        Magee-Womens Hospital of UPMC
      Aug 2, 2022

      Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System Trial in Tampa, Gainesville (Testosterone Enanthate,

      Terminated
      • Spinal Cord Injury
      • +10 more
      • Testosterone Enanthate
      • +3 more
      • Tampa, Florida
      • +1 more
      Jul 28, 2022

      Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Montreal (Group education sessions for parents plus usual

      Not yet recruiting
      • Diabetes Mellitus
      • +6 more
      • Group education sessions for parents plus usual diabetes care
      • Usual diabetes care
      • Montreal, Quebec, Canada
        Montreal Children's Hospital - McGill University Health Centre (
      Jul 6, 2022

      Diabetes, Type 2 Diabetes, Glucose Metabolism Disorders Trial in Kaohsiung (A digital foot self-management program)

      Recruiting
      • Diabetes Mellitus
      • +4 more
      • A digital foot self-management program
      • Kaohsiung, Taiwan
        Fooyin University
      Jul 1, 2022

      Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

      Completed
      • Carcinoma
      • +12 more
      • Ocoxin-Viusid
      • Havana, Cuba
        National Institute of Oncology and Radiobiology (INOR)
      Jul 5, 2022

      Dysglycemia in Individuals With Gestational Diabetes Immediately

      Not yet recruiting
      • Gestational Diabetes
      • +6 more
      • Freestyle Libre 2
      • (no location specified)
      Jun 21, 2022